As a Free StocksGuide user, you can view scores for all 7,013 stocks worldwide.
11 Analysts have issued a ChemoMetec forecast:
11 Analysts have issued a ChemoMetec forecast:
Jun '25 |
+/-
%
|
||
Revenue | 496 496 |
22%
22%
|
|
Gross Profit | 412 412 |
28%
28%
|
|
EBITDA | 258 258 |
39%
39%
|
EBIT (Operating Income) EBIT | 237 237 |
40%
40%
|
Net Profit | 186 186 |
37%
37%
|
In millions DKK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for fluid cell count and analysis. It operates through the following segments: Instruments, Consumer Goods, Service, and Others. The Instruments segment sells NucleoCounter NC-100, NC-200, NC250, and NC-3000. The Consumer Goods segment offers disposable cartridges, disposable analysis chambers, reagents, and test kits. The Service segment provides service packages and its corresponding guarantees. The Others segment offers measuring modules and accessories. The company was founded by Hans Martin Glensbjerg in 1977 and is headquartered in Allerod, Denmark.
Head office | Denmark |
CEO | Mr. Behrens |
Employees | 184 |
Founded | 1997 |
Website | chemometec.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.